Stroke is a leading cause of death and disability and a risk factor for vascular dementia, doubling the risk of later cognitive impairment. Our research spans the translational pipeline from basic experimental biology and trials of healthcare interventions through to implementing findings into practice.
We focus on understanding mechanisms of neuroimmune and vascular dysfunction, how they contribute to acute cerebrovascular diseases and vascular dementia, and the impact of these conditions.
We carry forward this knowledge to improve the process and outcomes of care and, ultimately, the quality of life for stroke survivors and their carers.
Our research is unique in combining life sciences, interdisciplinary clinical research and implementation science.
We cover all clinical subtypes of stroke (ischaemic and haemorrhagic) and vascular dementia and include all stages of clinical care (hyperacute through to community) for people with stroke.
We also have strong links to the Manchester Centre for Clinical Neurosciences.